Header Logo

Connection

RAYMOND CHO to Nootropic Agents

Back to Details
This is a "connection" page, showing publications RAYMOND CHO has written about Nootropic Agents.
RAYMOND CHO
Connection Strength
0.118
Nootropic Agents
  1. A proof-of-concept, randomized controlled trial of DAR-0100A, a dopamine-1 receptor agonist, for cognitive enhancement in schizophrenia. J Psychopharmacol. 2016 05; 30(5):428-35.
    View in: PubMed
    Score: 0.118
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.